MaxCyte, Inc. - TR-1: Notification of major holdings

MaxCyte, Inc. (MXCT.L) Share Price & News

Bid

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
103.55M

MaxCyte, Inc. Company Profile

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

MaxCyte, Inc. - Notice of Results

MaxCyte, Inc. - Total Voting Rights and Block Listing Return

MaxCyte, Inc. - Signing of Strategic Platform License

MaxCyte, Inc. - Exercise of options and PDMR dealing

MaxCyte, Inc. - Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. - Grant of Options, RSUs and PSUs and PDMR Dealing

MaxCyte, Inc. - Filing of form 10-K for FY ended December 31, 2023

MaxCyte, Inc. - Reports Q4 & FY 2023 Financial Results

MaxCyte, Inc. - TR-1: Notification of major holdings

MaxCyte, Inc. - Preliminary FY Results & 2024 Guidance

MaxCyte, Inc. - Total Voting Rights

MaxCyte, Inc. - Exercise of options and PDMR dealing

MaxCyte, Inc. - TR-1: Notification of major holdings

MaxCyte, Inc. - Notice of Results

MaxCyte, Inc. - Total Voting Rights

MaxCyte, Inc. - Director/PDMR Shareholding

MaxCyte, Inc. - Holding(s) in Company

MaxCyte, Inc. - Signing of Strategic Platform License

MaxCyte, Inc. - TR-1: Notification of major holdings

MaxCyte, Inc. (MXCT.L) Share Price & News

MaxCyte, Inc. Company Profile